QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waszczak, B. L. Articles by Walters, J. R. Search for Related Content PubMed PubMed Citation Articles by Waszczak, B. L. Articles by Walters, J. R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DEXTROAMPHETAMINE DOPAMINE

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 6, 120-126, Copyright © 1986 by Society for Neuroscience

ARTICLE

Endogenous dopamine can modulate inhibition of substantia nigra pars reticulata neurons elicited by GABA iontophoresis or striatal stimulation

BL Waszczak and JR Walters

Previous reports from this laboratory have described an ability of iontophoretically applied dopamine to attenuate the inhibitory effects of iontophoresed GABA on neurons of the substantia nigra pars reticulata. This finding raised the question of whether endogenous dopamine, released from dendrites of neighboring pars compacta dopamine neurons, might act as a neuromodulator which diminishes the inhibition of pars reticulata neurons evoked by either GABA iontophoresis or electrical stimulation of the striatonigral GABAergic pathway. Extracellular, single-unit activity of pars reticulata neurons was recorded in male rats anesthetized with chloral hydrate. In one set of studies, d-amphetamine, a drug reported to release dopamine from nigral dendrites, was administered intravenously (1.6 mg/kg) during regular, intermittent iontophoretic pulses of GABA. As had been previously observed with iontophoresed dopamine, i.v. amphetamine significantly lessened the inhibition of reticulata neurons produced by GABA application. This change was reflected by a decrease in GABA's inhibitory potency by 22% relative to the control level of inhibition achieved prior to amphetamine administration. Amphetamine caused no decreases in GABA's effectiveness, however, in animals that had previously received treatments that depleted or destroyed nigral dopamine stores, i.e., in rats pretreated with reserpine and alpha- methyl-p-tyrosine, or in rats with 6-hydroxydopamine lesions of the nigrostriatal dopamine pathway. In a second set of experiments, amphetamine or dopamine was delivered iontophoretically while monitoring the GABA-mediated (bicuculline-reversible) inhibition of reticulata neurons that can be elicited by striatal stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. A. Kliem, N. T. Maidment, L. C. Ackerson, S. Chen, Y. Smith, and T. Wichmann Activation of Nigral and Pallidal Dopamine D1-Like Receptors Modulates Basal Ganglia Outflow in Monkeys J Neurophysiol, September 1, 2007; 98(3): 1489 - 1500. [Abstract] [Full Text] [PDF]

				L. J. Gentet and S. R. Williams Dopamine Gates Action Potential Backpropagation in Midbrain Dopaminergic Neurons J. Neurosci., February 21, 2007; 27(8): 1892 - 1901. [Abstract] [Full Text] [PDF]

				M. Marti, C. Trapella, R. Viaro, and M. Morari The Nociceptin/Orphanin FQ Receptor Antagonist J-113397 and L-DOPA Additively Attenuate Experimental Parkinsonism through Overinhibition of the Nigrothalamic Pathway J. Neurosci., February 7, 2007; 27(6): 1297 - 1307. [Abstract] [Full Text] [PDF]

				F. Windels and E. A. Kiyatkin GABA, Not Glutamate, Controls the Activity of Substantia Nigra Reticulata Neurons in Awake, Unrestrained Rats J. Neurosci., July 28, 2004; 24(30): 6751 - 6754. [Abstract] [Full Text] [PDF]

				S. J. Cragg and S. A. Greenfield Differential Autoreceptor Control of Somatodendritic and Axon Terminal Dopamine Release in Substantia Nigra, Ventral Tegmental Area, and Striatum J. Neurosci., August 1, 1997; 17(15): 5738 - 5746. [Abstract] [Full Text] [PDF]

				A. Emmi, H. Rajabi, and J. Stewart Behavioral and Neurochemical Recovery from Partial 6-Hydroxydopamine Lesions of the Substantia Nigra Is Blocked by Daily Treatment with D1/D5, But Not D2, Dopamine Receptor Antagonists J. Neurosci., May 15, 1997; 17(10): 3840 - 3846. [Abstract] [Full Text] [PDF]

				S. J. Cragg, M. E. Rice, and S. A. Greenfield Heterogeneity of Electrically Evoked Dopamine Release and Reuptake in Substantia Nigra, Ventral Tegmental Area, and Striatum J Neurophysiol, February 1, 1997; 77(2): 863 - 873. [Abstract] [Full Text] [PDF]

				C. Yokoyama and H. Okamura Self-Injurious Behavior and Dopaminergic Neuron System in Neonatal 6-Hydroxydopamine-Lesioned Rat: 1. Dopaminergic Neurons and Receptors J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1016 - 1030. [Abstract] [Full Text]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help